|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000163001 |
Summary for CFAP36 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000163001 | Gene symbol | CFAP36 |
| Gene name | cilia and flagella associated protein 36 | |
| HGNC | 30540 | |
| Entrez ID | 112942 | |
| Gene type | protein_coding | |
| Synonyms | CFAP36|MGC15407|BARTL1 | |
| UniProtAcc | Q96G28 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CFAP36 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CFAP36 | 1.25e+03 | 1.45e+00 | 3.01e-01 | 4.84e+00 | 1.33e-06 | 9.30e-06 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for CFAP36 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CFAP36 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg04842553 | chr2:55518938 | CGI:chr2:55519539-55519863 | promoter | 5.19e-01 | 6.41e-01 | -1.97e+00 | 4.84e-02 | 4.86e-02 | -1.22e-01 |
| CHOL | cg06046912 | chr2:55520497 | CGI:chr2:55519539-55519863 | promoter,gene body | 1.52e-01 | 2.91e-01 | -2.65e+00 | 7.96e-03 | 1.92e-02 | -1.40e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for CFAP36 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CFAP36 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LGG | CFAP36-006 | chr2_55540756_+ | 2.40e-01 | 1.80e-01 | 2.19e+00 | 2.88e-02 | 4.72e-02 | 6.03e-02 |
| THCA | CFAP36-006 | chr2_55533575_+ | 4.46e-01 | 2.95e-01 | 2.21e+00 | 2.74e-02 | 4.91e-02 | 1.51e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CFAP36 |
TFs related to CFAP36.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | DMRTC2 | CFAP36 | 7.08e+00 | 9.88e-01 | 6.33e+00 | 1.22e-02 | Male-biased |
| ACC | DUX4 | CFAP36 | 4.81e+00 | 9.95e-01 | 3.64e+00 | 2.12e-03 | Male-biased |
| ACC | ELF3 | CFAP36 | 3.86e+00 | 9.85e-01 | 2.24e+00 | 3.02e-04 | Male-biased |
| ACC | FOXA3 | CFAP36 | 3.92e+00 | 9.87e-01 | 2.03e+00 | 8.63e-05 | Male-biased |
| ACC | FOXB1 | CFAP36 | 4.07e+00 | 9.90e-01 | 2.18e+00 | 8.73e-05 | Male-biased |
| ACC | FOXQ1 | CFAP36 | 4.13e+00 | 9.91e-01 | 2.57e+00 | 3.83e-04 | Male-biased |
| ACC | GABPA | CFAP36 | 3.05e+00 | 5.97e-03 | 4.00e+00 | 9.82e-01 | Female-biased |
| ACC | LHX3 | CFAP36 | 4.16e+00 | 9.90e-01 | 2.75e+00 | 7.49e-04 | Male-biased |
| ACC | NKX6-1 | CFAP36 | 3.76e+00 | 9.82e-01 | 1.89e+00 | 9.38e-05 | Male-biased |
| ACC | PBX4 | CFAP36 | 4.67e+00 | 9.94e-01 | 3.43e+00 | 1.64e-03 | Male-biased |
| ACC | SOX2 | CFAP36 | 4.16e+00 | 9.91e-01 | 2.66e+00 | 5.02e-04 | Male-biased |
| ACC | SOX21 | CFAP36 | 4.23e+00 | 9.90e-01 | 3.03e+00 | 1.84e-03 | Male-biased |
| ACC | SOX4 | CFAP36 | 3.97e+00 | 9.87e-01 | 2.61e+00 | 8.79e-04 | Male-biased |
| ACC | SOX7 | CFAP36 | 4.09e+00 | 9.90e-01 | 2.63e+00 | 5.79e-04 | Male-biased |
| ACC | SRY | CFAP36 | 4.63e+00 | 9.95e-01 | 3.18e+00 | 6.49e-04 | Male-biased |
| ACC | ZNF418 | CFAP36 | 3.75e+00 | 9.82e-01 | 9.98e-01 | 6.54e-07 | Male-biased |
| ACC | ZNF506 | CFAP36 | 2.16e+00 | 4.13e-04 | 3.73e+00 | 9.81e-01 | Female-biased |
| ACC | ZNF682 | CFAP36 | 1.52e+00 | 1.25e-05 | 3.79e+00 | 9.83e-01 | Female-biased |
| ACC | ZNF705G | CFAP36 | 3.97e+00 | 9.80e-01 | 3.11e+00 | 7.45e-03 | Male-biased |
| ACC | ZNF74 | CFAP36 | 4.25e+00 | 9.90e-01 | 3.10e+00 | 2.22e-03 | Male-biased |
| BLCA | EHF | CFAP36 | 4.63e+00 | 9.83e-01 | 3.87e+00 | 1.17e-02 | Male-biased |
| BLCA | ELF4 | CFAP36 | 4.43e+00 | 9.82e-01 | 3.66e+00 | 1.08e-02 | Male-biased |
| BLCA | ELK4 | CFAP36 | 4.58e+00 | 9.89e-01 | 3.57e+00 | 4.88e-03 | Male-biased |
| BLCA | ZFP64 | CFAP36 | 2.11e+00 | 1.68e-04 | 4.01e+00 | 9.83e-01 | Female-biased |
| BLCA | ZIM2 | CFAP36 | 1.97e+00 | 1.07e-04 | 3.98e+00 | 9.83e-01 | Female-biased |
| BLCA | ZNF200 | CFAP36 | 4.58e+00 | 9.90e-01 | 3.52e+00 | 4.14e-03 | Male-biased |
| BLCA | ZNF30 | CFAP36 | 2.29e+00 | 4.66e-04 | 3.92e+00 | 9.80e-01 | Female-biased |
| BLCA | ZNF566 | CFAP36 | 2.16e+00 | 2.35e-04 | 3.97e+00 | 9.82e-01 | Female-biased |
| BLCA | ZNF682 | CFAP36 | 2.07e+00 | 8.20e-05 | 4.14e+00 | 9.87e-01 | Female-biased |
| BLCA | ZSCAN30 | CFAP36 | 2.15e+00 | 2.54e-04 | 3.94e+00 | 9.81e-01 | Female-biased |
| LAML | ZNF418 | CFAP36 | 5.28e+00 | 9.85e-01 | 4.40e+00 | 1.19e-02 | Male-biased |
| PCPG | DUX4 | CFAP36 | 3.82e+00 | 6.37e-03 | 4.73e+00 | 9.89e-01 | Female-biased |
| PCPG | FOXA3 | CFAP36 | 2.26e+00 | 3.09e-04 | 3.78e+00 | 9.80e-01 | Female-biased |
| PCPG | FOXB1 | CFAP36 | 2.44e+00 | 4.05e-04 | 3.91e+00 | 9.84e-01 | Female-biased |
| PCPG | FOXQ1 | CFAP36 | 2.64e+00 | 8.16e-04 | 3.97e+00 | 9.85e-01 | Female-biased |
| PCPG | LHX3 | CFAP36 | 2.89e+00 | 9.92e-04 | 4.18e+00 | 9.89e-01 | Female-biased |
| PCPG | PBX4 | CFAP36 | 3.52e+00 | 5.38e-03 | 4.46e+00 | 9.88e-01 | Female-biased |
| PCPG | SOX2 | CFAP36 | 2.82e+00 | 2.00e-03 | 3.97e+00 | 9.84e-01 | Female-biased |
| PCPG | SOX21 | CFAP36 | 3.11e+00 | 3.01e-03 | 4.17e+00 | 9.87e-01 | Female-biased |
| PCPG | SOX7 | CFAP36 | 2.71e+00 | 1.16e-03 | 3.97e+00 | 9.85e-01 | Female-biased |
| PCPG | SRY | CFAP36 | 3.32e+00 | 1.75e-03 | 4.51e+00 | 9.92e-01 | Female-biased |
| PCPG | ZNF74 | CFAP36 | 3.24e+00 | 5.52e-03 | 4.17e+00 | 9.84e-01 | Female-biased |
CFAP36 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CFAP36 |
RBPs related to ES in CFAP36.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | ZCRB1 | exon_skip_325712 | 1.34e+01 | 9.99e-01 | 1.28e+01 | 9.23e-04 | Male-biased |
| CHOL | ZCRB1 | exon_skip_325712 | 1.33e+01 | 9.86e-01 | 1.30e+01 | 1.39e-02 | Male-biased |
| THCA | ZCRB1 | exon_skip_325712 | 1.26e+01 | 9.89e-01 | 1.24e+01 | 1.03e-02 | Male-biased |
| KICH | Fusip1 | exon_skip_325713 | 7.53e+00 | 9.87e-01 | 7.09e+00 | 2.95e-03 | Male-biased |
CFAP36 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12995774 | chr2:49932340:G:C | - | 0.0944092079565641 | 0.0166165076246292 | LUSC | Female-baised eQTL |
| rs13023905 | chr2:49899069:G:C | - | 0.0914320387448345 | 0.0245291369351367 | LUSC | Female-baised eQTL |
| rs17039592 | chr2:49969017:T:A | - | 0.0968852556701151 | 0.0361651664317007 | LUSC | Female-baised eQTL |
| rs13028383 | chr2:49847304:C:T | - | 0.0899686767228334 | 0.0412091874049134 | LUSC | Female-baised eQTL |
| rs62132436 | chr2:49937080:A:G | - | 0.0913118023724842 | 0.0456735749484065 | LUSC | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs59787338 | chr2:47080981:C:T | - | 0.219381842317601 | 0.0269869859532802 | SARC | Male-baised eQTL |
| rs11903212 | chr2:58196177:C:T | - | 0.100340505519836 | 0.0449264167566435 | LUAD | Male-baised eQTL |
| rs6739534 | chr2:51475127:A:T | - | 0.08316168083032 | 0.00778795874174038 | COAD | Male-baised eQTL |
| rs11900521 | chr2:49238235:C:T | - | 0.084782369414615 | 0.00986903506022464 | COAD | Male-baised eQTL |
| rs2067670 | chr2:49239515:C:T | - | 0.0828802238627931 | 0.0115671399758303 | COAD | Male-baised eQTL |
| rs17038496 | chr2:49238032:C:T | - | 0.0798445353367084 | 0.0157985949372473 | COAD | Male-baised eQTL |
| rs7598303 | chr2:49237628:T:C | - | 0.079306219470377 | 0.0171753730869718 | COAD | Male-baised eQTL |
| rs6758465 | chr2:57986702:A:G | - | 0.0761565732191857 | 0.0172479684724164 | COAD | Male-baised eQTL |
| rs2293359 | chr2:53969989:C:A | - | 0.0881192376560604 | 0.025927857033177 | COAD | Male-baised eQTL |
| rs12463540 | chr2:57977602:C:T | - | 0.0811331336912555 | 0.0261522514483054 | COAD | Male-baised eQTL |
| rs72808489 | chr2:57978660:C:T | - | 0.0811331336912555 | 0.0261522514483054 | COAD | Male-baised eQTL |
| rs7564612 | chr2:49239122:A:C | - | 0.0749907907423233 | 0.0268169790360186 | COAD | Male-baised eQTL |
| rs7605415 | chr2:49239264:T:C | - | 0.0749907907423233 | 0.0268169790360186 | COAD | Male-baised eQTL |
| rs10174346 | chr2:49240626:T:G | - | 0.0749907907423233 | 0.0268169790360186 | COAD | Male-baised eQTL |
| rs2067671 | chr2:49239645:A:G | - | 0.0736656318302467 | 0.0306785053701972 | COAD | Male-baised eQTL |
| rs6545430 | chr2:54561139:T:C | - | 0.0538086419095404 | 0.0342403431909926 | COAD | Male-baised eQTL |
| rs17050453 | chr2:59833361:T:G | - | 0.0719406389933248 | 0.0342410150635272 | COAD | Male-baised eQTL |
| rs6734780 | chr2:53338895:G:A | - | 0.1321139958863 | 0.0349092126658024 | COAD | Male-baised eQTL |
| rs56370078 | chr2:57980604:C:T | - | 0.0765180572739771 | 0.0364119722453613 | COAD | Male-baised eQTL |
| rs1518396 | chr2:57985668:C:T | - | 0.0765180572739771 | 0.0364119722453613 | COAD | Male-baised eQTL |
| rs67880350 | chr2:57999301:G:A | - | 0.0765180572739771 | 0.0364119722453613 | COAD | Male-baised eQTL |
| rs67993785 | chr2:57982879:G:A | - | 0.0764217974866137 | 0.0369497237262487 | COAD | Male-baised eQTL |
| rs2198756 | chr2:46685299:C:G | - | 0.0485144624298171 | 0.0387078450418176 | COAD | Male-baised eQTL |
| rs115659806 | chr2:58001691:G:A | - | 0.0913153023386172 | 0.0428199777903549 | COAD | Male-baised eQTL |
| rs6758763 | chr2:50440400:C:T | - | 0.0613232740240612 | 0.0428313053727324 | COAD | Male-baised eQTL |
| rs7558298 | chr2:59834262:G:A | - | 0.0680570084122569 | 0.0439448577683194 | COAD | Male-baised eQTL |
| rs117296869 | chr2:53971044:G:C | - | 0.084189781229309 | 0.0454375355063075 | COAD | Male-baised eQTL |
| rs12713262 | chr2:54562095:T:C | - | 0.0514258758639292 | 0.0477394274379961 | COAD | Male-baised eQTL |
| rs56100737 | chr2:54701233:G:A | - | 0.0481133324747642 | 0.0481112129878187 | COAD | Male-baised eQTL |
| rs13416474 | chr2:50310373:A:G | - | 0.0476682075318133 | 0.0485727589587277 | COAD | Male-baised eQTL |
| rs4671239 | chr2:55098236:C:T | - | -0.0653864787392494 | 0.048672830468914 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CFAP36 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |